Xenia Hotels & Resorts - XHR Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xenia Hotels & Resorts in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" XHR shares.
View XHR analyst ratings or view top-rated stocks.

5 Wall Street analysts have issued 12 month price targets for Xenia Hotels & Resorts' stock. Their XHR share price forecasts range from $17.00 to $22.00. On average, they predict the company's share price to reach $20.40 in the next year. This suggests a possible upside of 14.8% from the stock's current price.
View analysts price targets for XHR or view top-rated stocks among Wall Street analysts.

Xenia Hotels & Resorts' stock was trading at $18.11 at the beginning of the year. Since then, XHR stock has decreased by 1.9% and is now trading at $17.77.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our XHR earnings forecast.

Xenia Hotels & Resorts, Inc. (NYSE:XHR) announced its quarterly earnings results on Tuesday, November, 2nd. The real estate investment trust reported ($0.20) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.20). The real estate investment trust earned $172.78 million during the quarter, compared to analysts' expectations of $169.98 million. Xenia Hotels & Resorts had a negative net margin of 2.62% and a negative trailing twelve-month return on equity of 1.57%. During the same period in the prior year, the company earned ($0.27) EPS.

Xenia Hotels & Resorts updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of $1.49-$1.73 for the period. The company issued revenue guidance of -.

1 employees have rated Xenia Hotels & Resorts Chief Executive Officer Marcel Verbaas on Glassdoor.com. Marcel Verbaas has an approval rating of 100% among the company's employees. This puts Marcel Verbaas in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Xenia Hotels & Resorts to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Xenia Hotels & Resorts investors own include Pfizer (PFE), AT&T (T), Intel (INTC), Delta Air Lines (DAL), Starwood Property Trust (STWD), Bristol-Myers Squibb (BMY), DocuSign (DOCU), Gilead Sciences (GILD), Main Street Capital (MAIN) and Realty Income (O).

Xenia Hotels & Resorts trades on the New York Stock Exchange (NYSE) under the ticker symbol "XHR."

Xenia Hotels & Resorts' stock is owned by a number of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (2.64%), Northern Trust Corp (1.47%), Principal Financial Group Inc. (0.62%), Rhumbline Advisers (0.32%), Deutsche Bank AG (0.28%) and Asset Management One Co. Ltd. (0.21%). Insiders that own company stock include Atish Shah, Barry A N Bloom, Joseph T Johnson, Marcel Verbaas, Taylor C Kessel and Taylor C Kessel.
View institutional ownership trends.

Shares of XHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XHR stock can currently be purchased for approximately $17.77.

Xenia Hotels & Resorts (NYSE:XHR) has a market capitalization of $2.03 billion and generates $616.19 million in revenue each year. The real estate investment trust earns $-143,520,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis.

Xenia Hotels & Resorts' mailing address is 200 S. ORANGE AVENUE SUITE 2700, ORLANDO FL, 32801. The official website for the company is www.xeniareit.com. The real estate investment trust can be reached via phone at (407) 246-8100 or via fax at 866-748-7101.